E2027 (Hereinafter Referred to as Irsenontrine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for E2027 (Hereinafter Referred to as Irsenontrine), covering 2022-08-01 to 2022-08-01. Get the full timeline:
Most recent: Clinical Trial Update: Study To Evaluate the Efficacy, Safety and Tolerability of E2027 (Hereinafter Referred to as Irsenontrine) in Participants With Dementia With Lewy Bodies [Phase 2]